Mirus Bio receives ISO 13485:2016 certification, underscoring the quality of processes used to support GMP product portfolio. Read more
Mirus Bio receives ISO 13485:2016 certification, underscoring the quality of processes used to support GMP product portfolio. Read more
2-4x increase in AAV titer
>50% reduction in cost per dose, 2x does per bioreactor run
Improve product quality with better full:empty capsid ratios
Expert onsite FAS support
Transfection & complex delivery parameter process optimization
Improve consistency of scale-up
results
Fold increases in titer lead to massive saving per dose
Use ≥33% less pDNA with VirusGEN and less pDNA with VirusGEN and RevIT to drive lower total cost per batch
Evaluating new technologies during process development can be time-consuming. And while you want to integrate the best solutions to optimize your workflow, demands on your time can make it difficult.
That’s why we’ve introduced Transfection Adoption Partnership services. If you’re ready to take your transfection process to the next level and achieve at least a 2x improvement in titer, give us a call.
Our team of application scientists will partner with you to evaluate our VirusGEN® transfection reagent, head-to-head with your current process. We’ll eliminate the burden of managing the evaluation process with special membership benefits and pricing.
As part of the TAP program, you have access to a dedicated team that will partner with you to ensure success.
Your go-to point of contact for all things Mirus Bio
Our transfection expert who guides process optimization and evaluation
Mirus support team is a single communication away
